DNA origami technique is a widely used method to create customized, complex, spatially well-defined two-(2D) and three-dimensional (3D) DNA nanostructures.
Introduction
The specific binding between nucleobases (Watson-Crick base pairing) can be exploited in creating DNA-based nanomaterials and devices for numerous biomedical applications. The first DNA nanostructures were proposed and demonstrated by Nadrian 'Ned' Seeman in the 1980s (1) . Since then, various design strategies for DNA nanoarchitectures have been presented (2, 3) . One of them is a DNA origami (4) , which has proven to be a remarkably robust and straightforward method. With the DNA origami technique, it is possible to create customized and complex two-and three-dimensional nano-objects with nanometer-scale precision (4, 5) . Most commonly, origamis are formed by folding a long single-stranded DNA scaffold strand into a desired shape with a set of designed oligonucleotides, i.e. staple strands.
These staples are unique in sequence and they bind to specific locations at the scaffold strand, thus driving the exact assembly of the desired origami shape.
Importantly, DNA origami can be used to arrange different materials such as enzymes (6) , metal nanoparticles (7), and carbon nanotubes (8) . The authors have recently demonstrated how DNA origami shapes can be utilized in creating enzymatic nanoreactors (9) and metallic nanostructures (10) , and how the structures can be efficiently positioned and anchored on different substrates (11, 12) .
Due to their biocompatibility and modularity, DNA origamis are seen as promising candidates for developing biomedical delivery vehicles carrying drug molecules, functional binding sites and cell-targeting ligands (13, 14) . Although the recent studies indicate that e.g. DNA nanotubes (15) , CpG-sequence-coated DNA origamis (16) and various other shapes containing drug molecules (17, 18) can enter cells to some extent, the highly polar nature of the DNA structures seems to prevent efficient transfection (19) . Besides widely used transfection reagents, designed intercalators (20) , and lipid-membrane coatings (21) could be utilized to enhance the transfection efficiency or pharmacokinetic bioavailability of the DNA nanostructures. However, other types of further improved and sophisticated delivery systems are still urgently needed.
One attractive possibility to achieve enhanced transfection and protection of DNA nanostructures is to take advantage of virus particles (22, 23) . Viruses are natural transfection vectors and previous studies have already shown the possibility of using long double-stranded DNA or drug-loaded DNA micelles as templates to gain virus capsid protein -coated structures (24) (25) (26) . Here, we show in detail how DNA origami nanostructures can be coated and encapsulated using virus capsid proteins. For this, we utilize cowpea chlorotic mottle virus (CCMV), which has been successfully used in encapsulation of various macromolecules (27, 28) and as a component in proteinbased crystals and superlattices (29) (30) (31) . In brief, we combine ligated rectangular DNA origami templates (92 nm × 72 nm × 2 nm) with purified CCMV capsid protein (CP) dimers (32) in conditions where the self-assembly of proteins alone into higherorder structures is prevented. (33) . We show that CPs bind effectively to the surface of negatively charged DNA origami due to their positively charged N-terminus, and adapt configurations remarkably different from the naturally occurring icosahedral capsid structure. 
2.
Running buffer: 1× TAE (see above) with 11 mM MgAc or MgCl2.
3.
The DNA origami-CP samples: Prepare the samples 1 h before running the agarose gel.
4.
6× loading dye (New England Biolabs).
5.
M13mp18 ssDNA (New England Biolabs).
Methods

DNA origami preparation
The fabricated shape is a 72 nm x 92 nm x 2 nm rectangular origami (see Note 1).
The structure comprises of a 7249 bases long M13mp18 plasmid scaffold and 128
short oligonucleotides that fold the scaffold into a desired shape in a thermal annealing process. The staple design, core staple sequences and thermal ramp for folding have been adapted from Ref. (4) (see Note 2). After DNA origami formation by thermal annealing, the origami structures can be optionally ligated using T4 DNA ligase (see Note 3). The excess staple strands are removed after structure formation by a non-destructive spin-filtering procedure.
DNA origami annealing
This is a recipe for a ligated version of origami (if ligation is omitted, kinase reaction buffer (step number 3) and kinase (step number 5) can be replaced by in total 8 μL of distilled water). The structures are prepared as 50 μL quantities by mixing the following components: The staple strand mix is prepared by pipetting equal amounts of each 128 staple strands (10 μM) and mixing them together. This results in 0.781 μM concentration for each staple strand in the staple strand mix.
5.
3 μL T4 polynucleotide kinase (see Note 3). 6.
5.4 μL of 93 nM M13mp18 ssDNA.
The concentration of the scaffold strand in the total reaction volume of 50 μL is 10 nM. The staple strands are used in 10 times excess compared to the scaffold strand.
Thermal annealing ramp:
The solution is kept 1 hour at 37 °C, which is the optimum operational temperature for kinase, and immediately after that the origamis can be folded in an annealing process using a thermal cycler: The solution is annealed from 90 °C to 20 °C at a rate of 1 °C min -1 using 0.1 °C steps (i.e. 0.1 °C decrease every 6 seconds). After folding, the final concentration of DNA origami is 10 nM (assuming 100 % yield in folding).
Optional DNA origami ligation procedure
Ligation is carried out using T4 DNA ligase. The substances should be mixed in the order as listed below. The ligation procedure is prepared using 100 μL quantities.
After mixing, the solution is protected from light and let to incubate overnight at room temperature. The concentration of the DNA origami is diluted to 1 nM.
1.
9 μL 10× TAE Mg 2+ buffer (400 mM Tris, 190 mM acetic acid, 10 mM EDTA, 125 mM MgAc or MgCl2).
2.
67 μL distilled water.
3.
9 μL 10× ligase reaction buffer.
4.
10 μL annealed origami solution.
5.
5 μL T4 DNA ligase
Purification of DNA origami
Most of the excess staples can be removed in a non-destructive spin-filtering process.
Simultaneously, the buffer is exchanged (from TAE-based buffer to Hepes/NaOH buffer). For filtering, 0.5 mL Millipore Amicon Ultra Centrifugal Filters with 100 kDa MWCO are used. Filtration steps are described in detail below.
1. 500 μL of ligated DNA origami solution is injected into the filter. If ligation is not used, dilute 50 μL of DNA origami solution to 500 μL using Hepes/NaOH buffer.
2.
Solution is spun for 3 min using 14,000 rcf and the flowthrough is discarded.
3.
450 μL of Hepes/NaOH buffer is added to the filter and centrifuged again for 3 min using 14,000 rcf.
4.
The sample is spun in total 4 times repeating the procedure described above.
5.
After the last spinning the remaining solution can be gently pipetted out from the filter unit. After that the filter is turned upside down in a fresh container and spun 2 min using 1,000 rcf in order to collect the rest of the solution.
Typically, after filtration the volume of the solution is brought from 500 μL down to 17-20 μL. Dilute the solution back to 50 L by adding Hepes/NaOH origami buffer.
This results in pure DNA origami at approximately 10 nM concentration (assuming 100 % yield in spin-filtering) (see Note 4). ) against disassembly buffer for at least 8 hours using Slide-A-Lyzer® Mini or similar dialysis units (3.5 kDa MWCO).
CCMV CP isolation.
CP isolation: Collect the solution inside the dialysis unit and centrifuge it overnight (17,000 rcf, 4 °C). Collect the resulting supernatant carefully without
touching the RNA pellet (note that sometimes the RNA pellet can be relatively faint).
Dialyze the supernatant against clean buffer using dialysis units (3.5 kDa MWCO).
Storing CP solution: Collect the solution inside the dialysis unit and dilute it with clean buffer if needed (see Note 5).
Concentration and purity
Carry out measurements at room temperature with a UV/Vis spectrometer (e.g.
PerkinElmer LAMBDA 950). Use a quartz cuvette with a 0.3 cm light path. Subtract a reference spectra (blank buffer) from the spectra of actual samples.
CPs
Determine the CP concentration and purity by using the Beer-Lambert relationship, A280 = 280cCPl, where A280 is absorbance at 280 nm wavelength, 280 is the calculated extinction coefficient for CCMV protein monomer (23,590 M
) and l is the length of the light path in centimeters (0.3 cm).
CP concentration in different batches typically varies between 70 and 160 µM. Purity can be determined from A280/A260 ratio, which can vary between 1.3 and 1.5. The higher the ratio, the cleaner the CP solution.
DNA origami
DNA origami concentration (cDNA) was estimated using Beer-Lambert relationship, 
2.
Incubate at 4 C for 1 h.
3.
1.
In this protocol, the formation of the DNA origami-CP complexes is demonstrated using a 2D rectangular DNA origami. However, the coating method can be generalized and equally used for 3D origami shapes. 3D structures should be folded using a longer thermal ramp (e.g. lowering the temperature from 65 °C to 40
°C at a rate of 1 °C per 3 hours). In addition, 3D structures usually need more magnesium (20 mM) than 2D structures (12.5 mM) for the successful folding.
2.
The side-strands of the original DNA origami design (4) (strands at the edges of the design) are omitted in order to avoid undesired aggregation of DNA origamis,
i.e. to prevent their stacking to each other via blunt ends. It is highly recommended to take this stacking interaction into account if different DNA origami designs are used.
3. T4 polynucleotide kinase is applied for adding phosphate at the 5' end of staple strands for the following optional ligation procedure. Ligation might improve the thermal stability of DNA structures (35).
4.
To ensure the quality of the DNA origami folding and purification, the gel electrophoresis can be run (similarly as described in 2.5.1 and 3.5.1). M13mp18 scaffold strand can be used as a reference for the running speed of the DNA origami sample.
5.
It is useful to start the procedure by fabricating the DNA origamis first (decent long-term storing properties) and prepare CP solution only after that. This is fairly important, since the CPs start to degrade within one week after the preparation (the Nterminus (first ~30 amino acids) of CP is known to degrade within weeks, even if the solution is stored at 4 °C) (36).
6.
At a ratio of x = 0.08, the CPs start to bend the 2D DNA origami into tube-like conformations. When the ratio is increased to x = 0.64, round complexes are observed instead of tube-shaped structures. The tube-formation and folding of the rectangles could be attributed to a high flexibility and significantly twisted natural shape of a used DNA origami (twisting occurs when the origami is designed using a square lattice packing (37, 38) ). Therefore, if more rigid 3D origamis are used in the complex-formation, twisting and bending might not appear as prominent. The observed phenomena are likely caused by an electrostatic effect: the (positive) charge residues of CPs could effectively reduce repulsion between the DNA helices and further facilitate the complete folding of rectangles (similar folding can be observed when rectangular origamis are anchored onto substrates under localized electric fields (11, 39, 40) ). 
Sample details
